12.65
0.07 (0.56%)
0.07 (0.56%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Delcath Systems Inc | DCTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.56% | 12.65 | 12.31 | 12.74 | 12.60 | 12.58 | 18:00:58 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 12.10 | 13.00 | 0.90 | 6.92% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 408 | 28,375 | $ 12.62 | $ 358,066 | 70,111 | 6.06 - 12.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 185 | $ 12.65 | USD |
Delcath Systems Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 49.26M | 3.89M | 3.87M | $ 1.58M | $ - | -450.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 72.26k | 72.10% |
Delcath Systems News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DCTH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.77 | 12.85 | 11.75 | 12.58 | 33,038 | 0.88 | 7.48% |
| 1 Month | 9.06 | 12.90 | 8.60 | 11.56 | 62,061 | 3.59 | 39.62% |
| 3 Months | 7.68 | 12.90 | 7.15 | 9.66 | 65,395 | 4.97 | 64.71% |
| 6 Months | 3.77 | 12.90 | 6.06 | 9.28 | 69,700 | 8.88 | 235.54% |
| 1 Year | 3.77 | 12.90 | 6.06 | 9.28 | 69,700 | 8.88 | 235.54% |
| 3 Years | 0.0849 | 12.90 | 0.08 | 0.1535187 | 19,272,933 | 12.57 | 14,799.88% |
| 5 Years | 8.16 | 12.90 | 0.015 | 0.1777537 | 14,686,710 | 4.49 | 55.02% |
Delcath Systems Description
| Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. |
